CD8A and cerebral malaria: Along these lines, a recent study demonstrated that anti-LFA1 antibody treatment resulted in disease amelioration in the animal model of experimental cerebral malaria by a mechanism displacing CD8+ T cells from cerebrovascular ECs52.